HomeGOSS • NASDAQ
add
Gossamer Bio Inc
Previous close
$1.26
Day range
$1.26 - $1.36
Year range
$0.50 - $1.55
Market cap
301.01M USD
Avg Volume
1.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 9.89M | — |
Operating expense | 46.70M | 11.30% |
Net income | -36.64M | 12.62% |
Net profit margin | -370.49 | — |
Earnings per share | -0.16 | 15.79% |
EBITDA | -36.80M | 11.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 257.93M | 5.54% |
Total assets | 280.59M | 8.19% |
Total liabilities | 286.84M | 23.30% |
Total equity | -6.25M | — |
Shares outstanding | 227.30M | — |
Price to book | -42.00 | — |
Return on assets | -30.89% | — |
Return on capital | -42.91% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -36.64M | 12.62% |
Cash from operations | -39.72M | 24.05% |
Cash from investing | 22.06M | -64.23% |
Cash from financing | 504.00K | 119.73% |
Net change in cash | -17.05M | -352.49% |
Free cash flow | -20.61M | 41.06% |
About
Founded
2015
Website
Employees
144